How Cancer Stem Cells Drive Triple-Negative Breast Cancer
A new study from the labs of Justin Lathia, PhD, and Ofer Reizes, PhD, both of the Department of Cellular and Molecular Medicine, identifies a never-before described survival pathway in cancer stem cells (CSCs) that may serve as a potential target for new triple-negative breast cancer (TNBC) treatment therapies
Cleveland Clinic researchers report new therapy successfully reverses Alzheimer's in mice
Last week, Dr. Riqiang Yan of the Lerner Research Institute announced in a publication that a new therapy has successfully reversed Alzheimer’s disease in mice.
Inventor Story: Dan Cantillon, MD Discusses the Impact of the eCMU
Hear from Dan Cantillon, MD of the Heart and Vascular Institute on how his invention, the eCMU, has transformed hospital patient monitoring at Cleveland Clinic.